Summary of Significant Accounting Policies - Liability for Sale of Future Revenues (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Oct. 03, 2024 |
Dec. 31, 2024 |
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Proceeds from sale of future revenues | $ 57,000 | |
| Issuance costs | $ 1,756 | |
| DRI Healthcare Acquisitions LP | License Agreement | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| Proceeds from sale of future revenues | $ 57,000 | |
| Contingent upfront payment | 50,000 | |
| Issuance costs | 1,800 | |
| Liability for sale of future revenues, effective interest rate | 15.70% | |
| DRI Healthcare Acquisitions LP | License Agreement | Minimum | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| License fee | 5,000 | |
| DRI Healthcare Acquisitions LP | License Agreement | Maximum | ||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||
| License fee | $ 40,000 |